首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 0 毫秒
1.
正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.  相似文献   

2.
正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Spring of 2017)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.  相似文献   

3.
正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.  相似文献   

4.
<正>The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Spring of 2017)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.  相似文献   

5.
正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.Diagnosis upon biomarkers would aid in early and more efficient intervention,while prognostic  相似文献   

6.
<正>The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.  相似文献   

7.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall 2015)on the topic of‘‘Biomarkers for Diseases’’. As an emerging index,disease biomarkers have demonstrated the potential application in  相似文献   

8.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,  相似文献   

9.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the summer of 2015)on the topic of‘‘Biomarkers for Autoimmune Diseases’’.Autoimmune diseases(AIDs)are the third most common category of disease after cancer and heart disease and affect more than 5%of the general population.AIDs result  相似文献   

10.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,RNA,protein or metabolites,could gain highly sensitive and specific signals that truly reflect  相似文献   

11.
正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in June of 2015)on the topic of"Biomarkers for Diseases".As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,RNA,protein or metabolites,could gain highly  相似文献   

12.
The journal Genomics Proteomics & Bioinformatics (GPB) is now inviting submissions for a special issue (to be published in June of 2015) on the topic of "Biomarkers for Diseases".
As an emerging index, disease biomarkers have demonstrated the potential application in diagnosis and prognosis. The detection of the disease indicators at molecular level, DNA, RNA, protein or metabolites, could gain highly sensitive and specific signals that truly reflect the pathological changes and fully facilitate diagnostic analysis at early phase with invasive mode. Revolution of high-throughput techniques, such as genome-sequencing and mass spectrometers, greatly promotes the discovery and application of the disease biomarkers. The existing disease biomarkers have covered nearly all the macromolecular categories as well as their variants and modifications, including predisposing genetic variations (such as SNPs), mutations, epigenetic modifications, miRNAs, splice isoforms, abnormal proteins and autoantibodies. Although some biomarkers have been adopted in clinical practice, there are still great needs for studies on identifying new ones, understanding the existing ones and applying the well-studied ones in practice.  相似文献   

13.
正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a specialissue(to be published in April of 2015)on the topic of"Biomarkers for Autoimmune Diseases".Autoimmune diseases(AIDs)are the third most common category of disease after cancer and heart disease and affect more than 5%of the general population.AIDs result from a complex interaction of genetic and epigenetic  相似文献   

14.
正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in April of 2015)on the topic of"Biomarkers for Autoimmune Diseases".Autoimmune diseases(AIDs)are the third most common category of disease after cancer and heart disease and affect more than 5%of the general population.AIDs result from a complex interaction of genetic and epigenetic  相似文献   

15.
16.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,RNA  相似文献   

17.
正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the fall of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.  相似文献   

18.
正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the fall of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may  相似文献   

19.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of"Big data for biomedicine"to be published in the spring of 2016.For many complex diseases,the traditional"one drug for one disease"scenario may soon become history.The new concept of"precision medicine"will heavily rely on the collection of  相似文献   

20.
<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号